• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CDX
Click for more information
25.0% 15.0¢

CARDIEX LIMITED - Corporate Spotlight

Market Cap $17.65M  ! watchlist Created with Sketch. Add to my watchlist

CardieX Limited is an Australia-based digital health technology company. The Company... CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
15.0¢ 		Change
0.030(25.0%) 		Mkt cap ! $17.65M
Open High Low Value Volume
12.5¢ 15.5¢ 12.5¢ $109.5K 769.1K

Buyers (Bids)

No. Vol. Price($)
1 212 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 26442 2
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
Last
14.5¢ 		  Change
0.030 ( 16.0 %)
Open High Low Volume
13.5¢ 15.5¢ 12.5¢ 141247
Last updated 15.27pm 14/11/2024 ?
CDX (ASX) Chart

Top Stories

Biome reaches intellectual property milestone in strain development program

Biome Australia Ltd has achieved an important milestone in development of a biome strain, preparing for a transfer of intellectual property
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Recce scores $6.75M R&D rebate Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24.
HotCopper reacts as Resolute Mining told to pay US$160M if it wants its CEO back According to a report from Bloomberg, it appears Resolute Mining (ASX:RSG) CEO Terry Holohan is effectively being held ransom for US$160M.
Yangibana 33% complete says Hastings, as it provides clarification on funding Hastings Technology Metals Ltd has provided an update on how development of the Yangibana project in Western Australia is progressing
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.